BlackRock »

Y Mabs Therapeutics shares owned by BlackRock

Quarter-by-quarter ownership of Y Mabs Therapeutics (YMAB) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Y Mabs Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Y Mabs Therapeutics held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Y Mabs Therapeutics by BlackRock

Quarter filed Position value Share count Share price at filing
2024-09-30 $40M 3.0M 13.15

More positions owned by BlackRock

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
UnitedHealth (UNH)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p500 Etf (IVV)
Visa Com Cl A (V)

View all positions for BlackRock

Top funds holding Y Mabs Therapeutics

Paradigm Biocapital Advisors
BlackRock
BlackRock
Sofinnova Ventures
Vanguard Group
Cormorant Asset Management
Caligan Partners
Geode Capital Management
State Street Corporation
D. E. Shaw & Co
Pictet Asset Management Holding SA
Soleus Capital Management
Dimensional Fund Advisors
Northern Trust
Citadel Advisors

View all funds holding Y Mabs Therapeutics